about
Structures of intermediate transport states of ZneA, a Zn(II)/proton antiporterThe unexpected structure of the designed protein Octarellin V.1 forms a challenge for protein structure prediction toolsConformational changes in gastric H+/K+-ATPase monitored by difference Fourier-transform infrared spectroscopy and hydrogen/deuterium exchangeA FTIR imaging characterization of fibroblasts stimulated by various breast cancer cell linesInsights into Biochemical Alteration in Cancer-Associated Fibroblasts by using Novel Correlative SpectroscopyBiophysical characterization data of the artificial protein Octarellin V.1 and binding test with its X-ray helpersATR-FTIR: a "rejuvenated" tool to investigate amyloid proteins.Rationally selected basis proteins: a new approach to selecting proteins for spectroscopic secondary structure analysis.Evidence of an intramolecular interaction between the two domains of the BlaR1 penicillin receptor during the signal transduction.Characterization of a potent human interleukin-11 agonistReconstitution of holin activity with a synthetic peptide containing the 1-32 sequence region of EJh, the EJ-1 phage holin.Evaluation of the ordering of membranes in multilayer stacks built on an ATR-FTIR germanium crystal with atomic force microscopy: the case of the H(+),K(+)-ATPase-containing gastric tubulovesicle membranes.Evaluation of the information content in infrared spectra for protein secondary structure determination.The integrin binding site 2 (IBS2) in the talin rod domain is essential for linking integrin beta subunits to the cytoskeleton.Infrared spectroscopy study on the conformational changes leading to pore formation of the toxin sticholysin II.Sensor applications of attenuated total reflection infrared spectroscopy.Lipid quantification method using FTIR spectroscopy applied on cancer cell extracts.FTIR spectral signature of anticancer drugs. Can drug mode of action be identified?HTS-FTIR spectroscopy allows the classification of polyphenols according to their differential effects on the MDA-MB-231 breast cancer cell line.FTIR imaging of the 3D extracellular matrix used to grow colonies of breast cancer cell lines.Infrared imaging of MDA-MB-231 breast cancer cell line phenotypes in 2D and 3D cultures.Synthesis and in vitro characterization of platinum(II) anticancer coordinates using FTIR spectroscopy and NCI COMPARE: A fast method for new compound discovery.Infrared imaging of high density protein arrays.FTIR spectral signature of anticancer drug effects on PC-3 cancer cells: is there any influence of the cell cycle?FTIR spectroscopy: a new valuable tool to classify the effects of polyphenolic compounds on cancer cells.Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment.The effect of anticancer drugs on seven cell lines monitored by FTIR spectroscopy.Time dependence of cellular chemical changes induced in prostate PC-3 cancer cells by two structurally related cardenolides monitored by Fourier transform infrared (FT-IR) spectroscopy.The FTIR spectrum of prostate cancer cells allows the classification of anticancer drugs according to their mode of action.Ouabain-induced modifications of prostate cancer cell lipidome investigated with mass spectrometry and FTIR spectroscopy.Effects of the confluence rate on the FTIR spectrum of PC-3 prostate cancer cells in culture.Fourier transform infrared (FTIR) spectroscopy to monitor the cellular impact of newly synthesized platinum derivatives.FTIR spectral signature of the effect of cardiotonic steroids with antitumoral properties on a prostate cancer cell line.Protein secondary structure content in solution, films and tissues: redundancy and complementarity of the information content in circular dichroism, transmission and ATR FTIR spectra.IR spectroscopy as a new tool for evidencing antitumor drug signatures.Simultaneous Fitting of Absorption Spectra and Their Second Derivatives for an Improved Analysis of Protein Infrared Spectra.Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics.Interactions involved in the realignment of membrane-associated helices. An investigation using oriented solid-state NMR and attenuated total reflection Fourier transform infrared spectroscopies.Aptamer-based molecular recognition of lysergamine, metergoline and small ergot alkaloids.Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain.
P50
Q27680487-36235B6F-3DD1-49AB-B5AC-685B6D5EEEB1Q27704868-F5A27F85-8856-419A-8834-6EE0876656E6Q28257467-EBFC9B1C-161A-4E88-BB6F-CACA0626556EQ28544872-F3F3B759-2CB0-4AA4-A992-5A2C75171578Q28817630-5D2EBBAC-9953-4917-A103-90EAEEEB32ADQ28830445-F460E2D5-B59F-489F-92FA-E674122DE039Q30009837-A3A94A04-3327-4965-B5AD-54B808CFAF5BQ30333321-0974A6D3-31A5-4B6A-B195-2EC8E7B4EF53Q33197002-B83168ED-BE79-482B-8F0C-8D3D257E6226Q33349514-11888380-E3AA-4849-8C6E-CAE97AF15D52Q34162504-0CC12F82-F6AB-48B9-A063-0A7A8B463C6BQ34186670-C3AC57D6-6A4B-4357-9F94-9B1321EE1AF8Q34481464-B46A7129-D1D7-4A12-92C0-46DC7C09BF3BQ34618626-617B0AE7-68FA-46DD-9BFC-17087596E4A3Q36069687-A9F6C97E-3E52-48E2-B225-8134B9806258Q37312511-2CFDB2A0-9A9A-4553-90B2-CF8548031380Q38155322-66D527F1-C278-47E8-A475-6F9FA8FC5729Q38578003-B8C051F2-05A5-4DE0-AB89-9DF38D8251D1Q38727314-45EC4C40-891C-4C1C-8B90-446CC5B0E422Q38815954-0DBF718E-A5C9-4D07-B7B8-C66846EB3E22Q38922262-7A333E8C-1375-481F-967D-BD5FF7149C63Q38995930-FDB6B18A-31E3-48B3-B789-D91118372B1EQ39124942-0828FE82-5770-4879-AD60-9B1D115C850AQ39163977-7A07C0FE-A71D-4D40-8B35-A4D208766987Q39255810-872A2CA0-B572-4B3C-B26B-2F5BB18C1A59Q39273621-F75F9E61-D3D7-4795-B6DE-B554CEA8A5D6Q39335866-E87325B3-FF7F-4F38-9A5F-DB5887CED06FQ39531015-75DBD8F5-A660-4092-B07D-09A5FCFC3333Q39605411-E5238F10-FE43-462A-A5A2-E44AF2A47C98Q39622156-9ECE7CEA-5080-4C1E-85F4-F521E545DE1EQ39651435-D07B4E6F-B759-4374-9DF5-57D84F5B4C93Q39674860-61837B56-264D-4FD6-986F-492ED12E1088Q39676314-6300949D-F45E-4C04-9860-14D759B52CAFQ39835712-41AAFA3D-B24C-4E5F-8307-8FC1028EC590Q39878591-6AC861FD-335E-4750-B452-2EA08BFBDCC3Q40726751-90EC79E9-8EF7-4C24-BCBB-BC3F73DEA38FQ41850314-B266A713-6782-47AB-A2FC-251C561A5A31Q42677845-8F62D6FD-1089-4FBB-87E6-3EC1326A6170Q42752755-2E715812-0A01-4988-82F0-D89396239750Q42816401-AEDBD89F-B9FB-4FF8-94A2-688F76AF5493
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Erik Goormaghtigh
@ast
Erik Goormaghtigh
@en
Erik Goormaghtigh
@es
Erik Goormaghtigh
@nl
Erik Goormaghtigh
@sl
type
label
Erik Goormaghtigh
@ast
Erik Goormaghtigh
@en
Erik Goormaghtigh
@es
Erik Goormaghtigh
@nl
Erik Goormaghtigh
@sl
prefLabel
Erik Goormaghtigh
@ast
Erik Goormaghtigh
@en
Erik Goormaghtigh
@es
Erik Goormaghtigh
@nl
Erik Goormaghtigh
@sl
P106
P31
P496
0000-0002-2071-2262